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Treatment success rates for multidrug-resistant tuberculosis (MDR-TB) in South Africa
remain close to 50%. Lack of access to timely, decentralized care is a contributing factor.
We evaluated MDR-TB treatment outcomes from a clinical cohort with task-sharing between
a clinical nurse practitioner (CNP) and a medical officer (MO).
Methods
We completed a retrospective evaluation of outcomes from a prospective, programmati-
cally-based MDR-TB cohort who were enrolled and received care between 2012 and 2015
at a peri-urban hospital in KwaZulu-Natal, South Africa. Treatment was provided by either
by a CNP or MO.
Findings
The cohort included 197 participants with a median age of 33 years, 51% female, and 74%
co-infected with HIV. The CNP initiated 123 participants on treatment. Overall MDR-TB
treatment success rate in this cohort was 57.9%, significantly higher than the South African
national average of 45% in 2012 (p<00001) and similar to the provincal average of 60%
(p = NS). There were no significant differences by provider type: treatment success was
61% for patients initiated by the CNP and 52.7% for those initiated by the MO.
Interpretation
Clinics that adopted a task sharing approach for MDR-TB demonstrated greater treatment
success rates than the national average. Task-sharing between the CNP and MO did not
adversely impact treatment outcome with similar success rates noted. Task-sharing is a







Citation: Farley JE, Ndjeka N, Kelly AM,
Whitehouse E, Lachman S, Budhathoki C, et al.
(2017) Evaluation of a nurse practitioner-physician
task-sharing model for multidrug-resistant
tuberculosis in South Africa. PLoS ONE 12(8):
e0182780. https://doi.org/10.1371/journal.
pone.0182780
Editor: Etsuro Ito, Waseda University, JAPAN
Received: May 10, 2017
Accepted: July 24, 2017
Published: August 4, 2017
Copyright: This is an open access article, free of all
copyright, and may be freely reproduced,
distributed, transmitted, modified, built upon, or
otherwise used by anyone for any lawful purpose.
The work is made available under the Creative
Commons CC0 public domain dedication.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files. Data are from the study whose authors may
be contacted at jfarley1@jhu.edu. The authors have
added the available data into the Open ICPSR
public repository through the persistent URL
https://doi.org/10.3886/E100857V1. The data is
de-identified. However, because it contains
sensitive information, including history of HIV and
tuberculosis status as well as location, age and sex
identification it is provided with restricted access.
feasible option for South Africa to support decentralization without compromising patient
outcomes. Models that allow sharing of responsibility for MDR-TB may optimize the use of
human resources and improve access to care.
Introduction
Multidrug-resistant tuberculosis (MDR-TB) is a global epidemic, threatening progress towards
the World Health Organization’s (WHO) Global Plan to Stop TB [1]. According to the most
recent WHO report, MDR-TB, defined as TB with resistance to isoniazid and rifampin,
occurred in over 480,000 people in 2015 [2]. Of these, less than one quarter are known to be
receiving treatment [2]. Global treatment success rates for MDR-TB are exceptionally poor
with estimates ranging between 49 and 68% compared to 83% for drug-susceptible TB [2]. In
South Africa, MDR-TB treatment success is consistent with global norms with 50% of patients
having a successful outcome [2]. HIV co-infection complicates MDR-TB treatment and wors-
ens outcomes in South Africa where co-infection may exceed 70% [2–3]. Weaknesses in the
healthcare system including lengthy treatment delays are a large part of low success rates [3–
4].
Many countries have opted for centralized, hospital-based care in regional referral centers
to manage drug-resistant TB. This strategy falls short in high-prevalence areas where many
participants are concentrated in rural areas with limited hospital bed capacity [4]. In 2011, The
South African National Department of Health (NDoH) recommended decentralization of
MDR-TB treatment service to outpatient settings [5]. Decentralization required hospitals to
down-refer after treatement initiation to lower level care settings to facilitate care closer to
home. This model has shown improvements in patients’ overall care outcomes using physi-
cians to provide care at decentralized centers [4,6]. Unfortunately, scarce resources, treatment
related adverse effects and medical officer shortages pose challenges to implementing this
model to scale [7–8]. Further, this policy change was enacted with limited evidence to support
true decentralization to non-hospital settings or with non-physician providers.
One potential solution to this human resource challenge is task-sharing, a hybrid and more
cooperative form of task shifting, which is defined as the movement of medical officer-driven
clinical tasks to nurses with appropriate training [9]. Task-shifting has been implemented suc-
cessfully to expand access to care for people living with HIV across sub-Saharan Africa [10–
17]. Previous research on task-shifting concluded that it was an effective strategy for address-
ing human resource shortages for HIV treatment and care [18–21]. The most common inter-
vention was the delegation of initiating and monitoring antiretroviral therapy (ART) from
physicians to nurses. Nurse-led models of care have demonstrated equal or, in some cases,
improved outcomes for HIV-infected participants compared to standard, physician-led mod-
els of care. Equivalent or improved outcomes in the nurse-led models included increased
access to treatment [14,17,18], retention [10,11,14,16,20–21], patient acceptability [17,20–21],
improved viral load [10,12,15,19,21], decreased mortality [10–21], and reduced costs [13,18].
Similar benefits from utilizing nurse prescribers to alleviate human resource challenges have
also been demonstrated in other patient populations [22]. Task-sharing is a model similar to
task-shifting, but follows a shared approach to clinical care where healthcare workers share
responsibility on some activities while maintaining pre-existing tasks to share the workload
[14,23–24]. This study evaluated MDR-TB treatment outcomes from a task-sharing interven-
tion between a medical officer (MO) and clinical nurse practitioner (CNP) as a potential
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human resource solution to improve access to care and found that task-sharing is an effective
model for delivering safe patient care.
Materials and methods
Study site
A single, peri-urban district hospital with a stand alone MDR-TB treatment unit in KwaZulu-
Natal was chosen. The MDR-TB complex, included a 40 bed MDR-TB inpatient unit equally
divided between male and female wards. The outpatient clinic for MDR-TB is situated adja-
cent to the inpatient ward and the hospital’s outpatient HIV clinic. The majority of patients at
the site are admitted to the hospital ward for treatment initiation, however this varied based
on bed capacity. The site follows the South African national treatment guidelines for clinical
management. The catchment population for the hospital is noted to be 226,008 with six feeder
primary care clinics. It was the only MDR-TB treatment initiation site in the district at the
time of the study [25].
Clinical standard of care
Diagnosis of drug-resistant tuberculosis was made using standard culture-based approaches
with Mycobacterium growth indicator tubes (MGIT) followed by drug sensitivity testing
(DST) on positive samples. All samples were processed through the National Health Labora-
tory System. Patients diagnosed with MDR-TB received the clinical standard of care for
MDR-TB treatment in KwaZulu-Natal, South Africa, which for this area of the country
includes a six-drug regimen [6]. Treatment includes a weight-based dosing of an injectable
aminoglycoside (i.e., kanamycin) along with five oral medications: pyrazinamide, ethambutol,
moxifloxacin, terizidone, and ethionamide. The six-drug regimen continues for four months
after the point of sputum culture conversion with a minimum treatment duration of six
months (i.e., intensive phase). When the injectable regimen is completed, the continuation
phase then follows with the same oral regimen for a total treatment course of 24 months. Pyri-
doxine is a standard part of the regimen for the majority of patients, with dosages ranging
between 25mg and 150mg for the prevention of peripheral neuropathy.
Study enrollment
Participants were included in the programmatically-based observational cohort if they started
MDR-TB treatment between January 3, 2012 and December 31, 2012. Upon cohort comple-
tion, all participant charts were reviewed until the point of outcome, which included all treat-
ment completion and cure patients up to 24 months of follow-up. The final completion of
treatment on all participants was January 2015. In May 2015, the treatment outcomes for all
participants, received a second review and verification by the study team. The study was
approved by The Johns Hopkins University Institutional Review Board in Baltimore, Mary-
land, USA and the Medical Research Council Ethics Committee in Pretoria, South Africa. The
study was reviewed and approved by the Centers for Disease Control and Prevention under
the protocol entitled, “CO-INFECT Project: Nurse Case Management”.
Clinical procedures and assignment to MO or CNP
All patients presenting for MDR-TB care with culture-based evidence of isoniazid and rifampi-
cin resistance were eligible to receive care from either provider and assignment was based on
availability of the next provider. Study investigators had no role in treatment assignment. Par-
ticipants, however, who presented with a baseline body mass index (BMI) less than 18 kg/m2
Nurse practitioner-physician task-sharing model for MDR-TB treatment
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automatically received care from the medical officer due to severity of illness on presentation,
which was a programmatically-based decision. All participants were given the option to be fol-
lowed by the MO during the standard hospital consent process for treatment if they did not
wish to have their care completed by the CNP.
Clinical duties for both providers included all required care during the treatment period,
including inpatient services. Face to face and telephonic clinical consultation with the medical
officer was available and completed as needed from the CNP throughout the course of treat-
ment. In general, however, each clinician managed their assigned caseload unless out of the
office, at which time the other clinician provided back-up clinical coverage for the absent
member’s caseload. As part of current standardized care in South Africa, all patients with
MDR-TB sign a one-page indemnity form for treatment that details the treatment regimen,
provider options and basic expectations associated with the treatment course.
Treatment outcomes based on the South African NDoH guidelines are determined by spu-
tum culture results and include treatment success (cure/completion of therapy), death (for any
cause), failure (worsening drug resistance necessitating change in treatment), and default,
which is now known as loss to follow-up (interruption of treatment for two consecutive
months) [6]. Process indicators include the time to event for the outcome and length of inpa-
tient stay. For the purposes of this study, clinical treatment outcome as defined by the treating
provider was used as the categorical study outcome. Demographic, clinical and process vari-
ables were collected from the study participants.
Pre-intervention clinical preparation of CNP and MO
The CNP’s prerequisite training included an advanced diploma in primary healthcare manage-
ment (i.e., 18-month course of study after basic registered nurse training) and training in
nurse-initiation and management of anti-retroviral therapy (NIMART). The MO’s prerequi-
site training included a 5-year Bachelor’s of Medicine (MBBCh) with an additional year of
community service and training in HIV clinical management through an Advanced Post
Graduate Diploma. The MO had also completed a one-week skills building short-course devel-
oped by The Johns Hopkins University School of Nursing in the diagnosis, treatment, and
management of MDR-TB. Both the MO and CNP had extensive prior experience in the study
hospital site. After hire, the CNP participated in the same one-week short course as the MO
followed by an intensive one-week physical exam and health assessment skills update in the
MDR-TB unit. Study team members with substantial MDR-TB clinical knowledge use a stan-
dardized competency-based tool, developed by the study team, to validate the CNPs baseline
clinical skills through direct observation. After this evaluation the CNP received a one-month
period of clinical mentoring by MOs at two regional drug-resistant TB centers in the province.
Ancillary training and clinical mentoring were provided to the CNP during this period of
supervised clinical mentorship in the following MDR-TB activities: chest x-ray evaluation and
interpretation, laboratory monitoring, adverse treatment effects and their management as well
as audiometry monitoring and interpretation.
Statistical analysis
We computed descriptive statistics of the sample overall, and by provider type (CNP vs. MO).
Medians (interquartile range, IQR) were calculated for skewed continuous variables and fre-
quencies (%) were calculated for categorical variables. A Wilcoxon rank-sum test was used to
compare the two groups (CNP vs. MO) for continuous patient characteristics and outcome
variables and a Chi-square test was used to compare proportion of treatment outcome type
between provider types. A one-sample z-test was used to compare the success rate in this
Nurse practitioner-physician task-sharing model for MDR-TB treatment
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cohort with the national programmatic outcomes data from South Africa. The treatment out-
come was analyzed as proportion of outcome and also as time to an event. A multivariate Cox
proportional hazards model was used to examine the association between provider type and
time to a treatment outcome to evaluate type-specific hazards controlling for age, sex and base-
line HIV status [26]. Significance was evaluated at alpha = 0.05 for all two-sided statistical
tests.
Results
Two-hundred twelve participants presented with MDR-TB for treatment at this site. Fifteen
participants (7%) transferred their care to another facility making them ineligible for the final
cohort analysis. One hundred ninety-seven participants, 101 (51.3%) female, with a median
age of 33 years (IQR = 26–40) and a median body mass index (BMI) of 19.7 (IQR = 16.4–22.7)
were enrolled. HIV status at enrollment was known for all but one patient with 145 (74%) co-
infected with HIV (median CD4 count 250 cells per μL, IQR = 141–385) and of those, 108
(74.5%) were on ART at enrollment. The majority of participants (163, 82.7%) were admitted
to the hospital for treatment initiation. BMI was a significantly different (p = 0.049) variable at
baseline between the two providers (Table 1) which matched enrollment criteria. Of the 197
Table 1. Patient characteristics by provider type.
Characteristics Overall (n = 197) CNP (n = 123) MO (n = 74)
N, Median (IQR) or n (%)† N, Median (IQR) or n (%)† N, Median (IQR) or n (%)† P-value*
Age (years) 197, 33.0 123, 34.0 74, 31.5 0.226
(26–40) (26–41) (26–38)
Female 101 61 40 0.544
(51.3%) (49.6%) (54.1%)
BMI 140, 19.7 116, 19.9 24, 16.9 0.049
(16.4–22.7) (16.9–22.8) (14.4–21.6)
Weight (kg) 193, 53.5 123, 54 70, 52 0.292
(46.2–60) (47–60) (45–60)
Unemployed‡ 138/185 86/117 52/68 0.655
(74.6%) (73.5%) (76.5%)
HIV positive at baseline 145/196 90/123 55/73 0.738
(74.0%) (73.2%) (75.3%)
ART use at baseline among HIV positives 108/145 65/90 43/55 0.424
(74.5%) (72.2%) (78.2%)
CD4 count at baseline 137, 250 86, 225.5 51, 284 0.795
(141–385) (124–412) (157–378)
Time from MDRTB diagnosis to treatment initiation
(days)
197, 71 123, 72 74, 71 0.685
(51–92) (50–100) (51–88)
Community/Admission
Inpatient Unit 163 (82.7%) 101 (82.1%) 62 (83.8%) 0.406
Community 12 (6.1%) 6 (4.9%) 6 (8.1%)
Admitted Later 22 (11.2%) 16 (13.0%) 6 (8.1%)
*P-value from Wilcoxon rank-sum test for continuous variables, from Chi-square test for categorical variables; Unit = patients who initiated treatment as an
inpatient; community = patients who initiated treatment as an outpatient; admitted later = patients who initiated treatment as an outpatient due to lack of bed
availability, but who were subsequently admitted when a bed became available.
†Median (IQR = Q1-Q3) for continuous variables; n (%) for categorical variable, denominator (N) provided if different from given in header.
‡6 students excluded (from employment categories)
https://doi.org/10.1371/journal.pone.0182780.t001
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participants, 123 (62.4%) were initiated and followed on treatment by the CNP and 74 (37.6%)
initiated by the MO with a similar time to treatment initiation (Table 1). Overall, patient char-
acteristcs were nicely balanced, except as planned for BMI, between the two groups (Table 1).
No participants requested reassignment during the period of follow-up.
MDR-TB treatment outcomes
Treatment success for the cohort was 57.9% and significantly higher than the 45% national
norm (z = 3.70, p<0.0001) for the 2012 South African cohort amongst 8,435 patients and simi-
lar to the 60% success rate for KwaZulu-Natal province amongst 3,190 patients (p = NS).
Eleven (5.6%) participants experienced treatment failure, 33 (16.8%) died, and 39 (19.8%)
were lost to follow-up (Fig 1). Comparing treatment outcomes based on provider type, success
was documented for 75 (61%) of the CNP-assigned participants and 39 (52.7%) of the MO-
Fig 1. Participant enrollment and MDR-TB treatment outcomes between CNP and MO.
https://doi.org/10.1371/journal.pone.0182780.g001
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assigned participants, with similar success rates. Median length of stay (days) was shorter in
the MO group (81, IQR = 54–116) than CNP group (104, IQR = 77–132, p = 0.015) (Table 2).
In the multivariate model, hazard of a treatment outcome as a competing event was not signifi-
cantly different by provider type controlling for age, sex and HIV status (Table 3). There was
no significant difference by HIV status for either cure, failure or lost to follow-up; however,
hazard of death was 2.75 times higher in HIV positive patients than negative patients after con-
trolling for age, sex and provider type (p = 0.044). Age was also associated with an increased
hazard (hazard ratio [HR] 1.06, p = 0.001) for death, with 6% increase in hazard of death with
an additional year of patient age after adjusting for sex, HIV status and provider type.
Table 2. Patient outcome data by provider type.
Characteristics Overall (n = 197) CNP (n = 123) MO (n = 74)
N, Median (IQR) or n (%)† N, Median (IQR) or n (%)† N, Median (IQR) or n (%)† P-value*
Time from Tx start to culture conversion (days) 160, 56 106, 56 54, 58 0.840
(29–92) (29–92) (28–92)
Length of intensive phase (days) 153, 196 100, 196 53, 198 0.632
(181–212) (186–211) (180–215)
Time from Tx start to Outcome (days)
Success 728 (709–739) 728 (709–740) 729 (708–739) 0.363 (HR: 0.83‡)
Failure 85 (18–188) 85 (34–85) 92 (14–237) 0.200 (HR: 2.17‡)
Death 46 (16–155) 71 (18–159) 26 (2–155) 0.243 (HR: 1.50‡)
Loss to follow-up 524 (331–661) 545 (370–687) 468 (320–622) 0.903 (HR: 1.04‡)
Clinical Outcome 0.420
Success 114 (57.9%) 75 (61.0%) 39 (52.7%)
Failure 11 (5.6%) 5 (4.1%) 6 (8.1%)
Death 33 (16.8%) 18 (14.6%) 15 (20.3%)
Loss to follow-up 39 (19.8%) 25 (20.3%) 14 (18.9%)
Length of stay (inpatient days) 176, 95 112, 104 64, 81 0.015
(61–122) (77–132) (54–116)
*P-value from Wilcoxon rank-sum test for continuous variables, and from Chi-square test for categorical variables; Tx = treatment; Success = cure and
treatment completion
†Median (IQR = Q1-Q3) for continuous variables; n (%) for categorical variable
‡ HR: Hazard ratio from unadjusted MO to CNP comparison from a time to event model
https://doi.org/10.1371/journal.pone.0182780.t002
Table 3. Multivariate Cox proportional harzard model on time to one of the four treatment outcomes for comparison of cause-specific hazard
between provider type.
Success Failure Default Death
HR 95% CI P-value* HR 95% CI P-value* HR 95% CI P-value* HR 95% CI P-value*
Age (years) 1.00 0.99, 1.02 0.641 0.98 0.92, 1.04 0.491 0.97 0.94, 1.01 0.143 1.06 1.02, 1.09 0.001
Sex Female Male (ref) 1.02 0.70, 1.50 0.902 0.36 0.09, 1.47 0.155 0.91 0.46, 1.79 0.775 0.57 0.28, 1.16 0.120
HIV status Positive Negative (ref) 0.85 0.55, 1.31 0.457 0.40 0.11, 1.41 0.153 1.14 0.53, 2.44 0.733 2.75 1.03, 7.36 0.044
Provider† MO CNP (ref) 0.84 0.55, 1.28 0.413 2.43 0.73, 8.05 0.147 1.08 0.56, 2.09 0.819 1.70 0.85, 3.41 0.134
*P-value for Wald test
† Adjusting for age, sex, and baseline HIV status
MO, medical officer
CNP, clinical nurse practitioner
https://doi.org/10.1371/journal.pone.0182780.t003
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Discussion
In a prospective, programmatically-based, observational cohort, in a peri-urban site with over
70% HIV co-infection, a task-sharing approach for MDR-TB demonstrated greater treatment
success rates (57.9%) than the national average (45%).Task-sharing between the providers did
not adversely impact treatment outcome. Process indicators and clinical outcomes were simi-
lar between providers, with the one exception of length of stay, which was shorter in the MO-
led group. These findings demonstrate that nurse-led treatment did not compromise patient
care. These findings support the potential for task-sharing for MDR-TB treatment initiation
and management between medical officers and clinical nurse practitioners to work in some
settings. Participants with HIV and increasing age had an increased hazard for death, which
was independent of provider assignment and consistent with previously published literature
[2–4].
These findings add further support to previous studies conducted in under-resourced African
settings that utilize nurse-led models of care to manage HIV infection [10–17]. Decentralization
of drug-resistant TB care, as a key policy platform of The South African National Department of
Health, is designed to improve timely access to treatment. In this model, the use of culture-based
diagnostic methods was the main reason for a median time to treatment initiation of 71 days.
Presently, the country has fully implemented GeneXpert testing with results available in less than
3 days for most sites. As such, we urgently need data to inform current time between diagnosis
and treatment initiation to support the importance of the expansion of such task-sharing pro-
grams. Decentralized, MO-led models of care are demonstrating improved outcomes in South
Africa when compared to MO-led centralized approaches [27]; however, the necessary human
resources to ensure all treatment sites have a MO do not exist in much of the country. A task-
sharing nurse based model may alleviate this gap in human resources while maintaining high
quality care.
While this evaluation of a CNP-MO MDR-TB program is the first of its kind and demon-
strates programmatic outcomes exceeding those at the country level, limitations exist. The
study was limited to retrospective abstraction of clinical records and documentation describ-
ing the clinical care for each patient. While this may have limited impact on the final treatment
outcome determination, it limits the standardization of the type, frequency and preciseness
one might anticipate in a more controlled research evaluation. To avoid missing data–mainly
from lost or damaged medical files—our research team visited the site on a quarterly basis to
retrospectively abstract data from the medical record. We also know that the treating clinical
team was limited, and consisted of only one MO and one CNP initiating and managing
MDR-TB treatment at the clinic, a circumstance not unusual in the South African context.
This resulted, however, in the MO and CNP supporting one another during periods of illness
or extended leave of absence. Although this limited the granular nature of our comparison, we
felt that this improved generalizability and was ultimately a strength of the task-sharing model
in a real-world setting, as the sharing of patient responsibility benefited both clinicians. The
cross coverage needs that arose from the real world human resource challenge that exist
resulted in approximately four months where the CNP was the sole clinician and another two
months where the MO was the sole clinician. In both circumstances, participants received care
outside of their original patient assignment. It is important to note that without such a model
the MDR-TB program would have been without a trained MDR-TB care provider for approxi-
mately four months in an MO-only model. In the year prior to the programmatic implementa-
tion of this approach, this site experienced a period of more than six months without a trained
clinician responsible for managing MDR-TB participants. It is important to note that no
increase in death, default nor failure was noted during the time the CNP provided sole
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coverage. While the CNP can take on much of the patient burden thereby freeing the MO for
care of more complicated MDR-TB cases, this circumstance channels sicker patients into the
MO’s care and may bias outcome comparisons. In this cohort, the MO did manage partici-
pants who were significantly underweight (BMI< 18) on presentation to care, but this did not
lead to differences in treatment outcome. It does likely account for the slightly lower success
rates and lower inpatient days for the MO. Another possible explanation for this finding is that
the MO had greater clinical experience and therefore felt more comfortable releasing the
patient from the hospital earlier. Finally, as an observational study, this descriptive analysis
does not offer the necessary evidence to support large scale implementation; however these
data are promising and suggest the need for additional randomized evaluations.
Task-sharing is a feasible option for the peri-urban areas in South Africa to support decen-
tralization efforts without compromising patient outcomes. Further evaluation through ran-
domized controlled trials is required to more fully determine the impact of nurse-led models
of MDR-TB care. As access to care remains a priority, the South African NDoH is presently
decentralizing care to community health centers using the nurse-led model of care that has
been presented in this study [28–29].
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